Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts

Emanuele Cozzi, Paolo Simioni, Massimo Boldrin, Michela Seveso, Fiorella Calabrese, Nicola Baldan, Roberto Busetto, Daniela Tormene, Sabrina Gavasso, Massimo Castagnaro, Yann Echelard, Tim Rice, Mario Plebani, Paolo Carraro, Erika Bosio, Marialuisa Valente, Antonio Pagnan, Gaetano Thiene, Ermanno Ancona

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

BACKGROUND: Fibrin deposition is central to the acute humoral rejection process occurring in the presence of consumptive coagulopathy when pig organs are transplanted into primates.

METHODS: To assess whether strategies aimed at preventing fibrin formation may extend xenograft survival, we administered high daily doses of recombinant human antithrombin (rhAT) (500 U/kg twice daily) to obtain both anticoagulant and anti-inflammatory effects in immunosuppressed primate recipients of porcine kidneys.

RESULTS: Some degree of consumptive coagulopathy developed in both rhAT-treated (n=3) and untreated (n=3) primates. No major differences in the coagulation parameters analyzed were observed between the 2 groups. Similarly, no difference in survival was seen between rhAT-treated (20.6+/-4 days; range: 15-23 days) and untreated animals (17.3+/-11.6 days; range: 7-30 days), although the rhAT-treated primates had a higher bleeding tendency. Despite the high daily dose of rhAT, considerable fibrin deposition was observed in the graft as early as 2 weeks after transplantation.

CONCLUSIONS: These results suggest that a high daily dose of rhAT fails to influence survival or prevent fibrin formation and deposition in the graft in our pig-to-primate model. However, the potential role of rhAT administered in combination with heparins or other clotting inhibitor concentrates in this model remains to be determined.

Original languageEnglish
Pages (from-to)1501-10
Number of pages10
JournalTransplantation
Volume80
Issue number10
Publication statusPublished - 27 Nov 2005
Externally publishedYes

Fingerprint Dive into the research topics of 'Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts'. Together they form a unique fingerprint.

  • Cite this

    Cozzi, E., Simioni, P., Boldrin, M., Seveso, M., Calabrese, F., Baldan, N., Busetto, R., Tormene, D., Gavasso, S., Castagnaro, M., Echelard, Y., Rice, T., Plebani, M., Carraro, P., Bosio, E., Valente, M., Pagnan, A., Thiene, G., & Ancona, E. (2005). Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts. Transplantation, 80(10), 1501-10.